Evonik Corporation

ABOUT EVONIK

BIOMATERIAL SOLUTIONS FOR IMPLANTABLE MEDICAL DEVICES

As a global biomaterials leader, Evonik serves as a development partner and solutions provider to many of the world's largest and most innovative medical device companies. Our portfolio of biomaterials, technologies and application services are used by our customers to enhance the bioavailability, safety and performance of their products.

A GLOBAL BIOMATERIALS DEVELOPMENT PARTNER AND SOLUTIONS PROVIDER FOR MEDICAL DEVICES

The implantable medical devices used across application areas including cardiovascular disease, orthopedics and wound healing continue to become more specialized and personalized. One key enabling factor driving this market evolution is the development of advanced biomaterials that can optimize medical device safety, biocompatibility and performance. As a global leader for biomaterials with a broad portfolio of products, technologies and services, Evonik has served as a development partner and solutions provider to many of the world’s largest and most innovative medical device companies for more than 30 years. This portfolio includes a range of bioresorbable polymers, surface modification technologies, and services relating to custom polymer synthesis, and the development and scale-up of medical device parts to match your specific application requirements.

The RESOMER® portfolio of biodegradable polymers for implantable medical devices

RESOMER® is the world’s leading brand of bioresorbable polymers for use with implantable medical devices, with more than 30 years of safety and supply security. The breadth and versatility of RESOMER® polymers make them ideal for use across a broad range of orthopedic, vascular, wound closure and other medical device applications. Degradation profiles can span from a few weeks to more than four years. The portfolio of polymers for medical devices includes a range of standard and custom grades of homo-polymers, copolymers and block co-polymers including lactide, glycolide, trimethylene carbonate, p-dioxanone and ε-caprolactone. A range of filaments and powders are also available for use in the high-resolution 3D printing of implantable medical devices using Selective Laser Sintering (SLS) and Fused Filament Fabrication (FFF) technologies.

Medical device CMO partner for custom polymer synthesis

Leveraging more than 60 years of market leadership in the design, synthesis, and supply of high-quality polymers, Evonik provides medical device companies with a safe and reliable choice for the contract outsourcing of their proprietary biomaterials. From our medical device centers of excellence in the U.S. and Germany, we can offer an integrated range of CMO services from initial scale-up through to large-scale commercial production. When combined with other application development services available, we can serve as a single partner for the production of your proprietary polymer, and the development of the final medical device part until it is in your hands.

Endexo® surface modification technology to improve medical device functionality and safety

Endexo® is a proprietary additive technology that enhances the biocompatibility of medical devices that come into contact with blood, tissue or other biological fluids. The low molecular weight fluoro-oligomers used in Endexo® are incorporated during the device manufacturing process and migrate to within nanometers of the surface. By suppressing procoagulant protein conformation, decreasing platelet adhesion and inhibiting platelet activation, the Endexo® technology reduces the risk of thrombotic events. It also suppresses bacteria adhesion and biofilm formation to reduce infection risk. Commercially proven and compatible for use with a range of base polymers and manufacturing techniques, Endexo® represents a simple, value-based surface modification technology that is suitable for use across a wide range of medical device applications.

Application technology services for implantable medical device projects

Evonik has decades of expertise in the design and production of functional biomaterials suitable for implantable Class II and III medical devices. Our Medical Device Competence Center in the U.S. and Application Labs in Germany and China ensure responsive and reliable project execution. Our technical knowhow and integrated range of services can help to not only reduce complexity but accelerate speed to market and enhance the performance of your medical device. Services are available for use across a wide range of medical device applications including polymer synthesis and design, polymer processing, feasibility samples including rapid 3D prototyping, analysis and characterization. Regulatory data and other medical device support is also available. Fields of expertise include:

Orthopedic applications such as interference screws, to optimize properties including insertion torque, bone ingrowth, osteo-conductivity and minimize inflammation
Cardiovascular applications such as bioresorbable stents, to enhance properties including radial strength, ductility and scaffold thickness, or together with surface modification technologies reduce thrombosis and infection risk
Wound healing applications such as sutures and clips, to provide proprietary solutions to accelerate degradation, increase strength and durability, or enhance dimensional stability
Additional expertise with dental mesh, soft tissue fillers and tissue engineering scaffolds

Specialized medical device products and services

RESOMER® Composite with distinct osteoconductive properties to enhance bone fixation devices
RESOMER® filament, powder and granulate-based biodegradable materials for 3D printing of high-resolution device parts used with medical implants
Custom-made biodegradable polymers and custom synthesis of proprietary polymers
Advanced recombinant collagen platform for use with medical implant devices and other healthcare products

CONTACT INFORMATION

Evonik Corporation

2 Turner Place

Piscataway, NJ 08854

UNITED STATES

Phone: (732) 981-5021

Contact: Francine Clark

Request More Information

Visit Our Website

FEATURED ARTICLES

Biosynthetic Cellulose For Wound Healing – Your Questions Answered

Biosynthetic cellulose is a nature-inspired material that can be used to reduce pain and risk of infection for wounds such as burns. Dr. Uwe Beekmann, head of R&D for JeNaCell, discusses the story behind biosynthetic cellulose and what developments the future holds.
Rejuvenating And Regenerating The Skin With Biodegradable Polymers

Rejuvenating and regenerating the skin with biodegradable polymers and non-animal-derived collagen helps restore and heal damaged and aging skin.
Print Your Way To Success: Selective Laser Sintering (SLS)

Over the few past years, 3D printing technologies have expanded the capabilities to produce other types of biodegradable implants. Bioresorbable polymers such as RESOMER® have been used for decades in sports medicine, orthopedic, and surgical applications.
Fine-Tuning Your Filament: 3D Printing Of Medical Implants

In this case study, Evonik discusses how RESOMER® can be used in 3D-printed devices via Fused Filament Fabrication (FFF).
Biosynthetic Cellulose – Nature’s Secret To Better Wound Healing

Advanced wound dressings made of biosynthetic cellulose have been developed by JeNaCell, a small biotech company, now part of Evonik. In this interview, Dr. Uwe Beekmann, head of R&D for JeNaCell, reviews what biosynthetic cellulose is, how it is made, and potential applications.
Exclusive Synthesis - API, HPAPI, And Intermediates

Evonik is one of the world's top 3 CMOs for API and intermediates. The brochure offers insight into their capabilities and the technologies they use to address the specific needs of the largest and most complex synthesis problems life science companies face today.
A Functional Application For A Commercial Biomaterials Surface Modification Technology

The surface design of devices should aim to minimize trauma during insertion and removal, reduce tissue inflammation, enable maneuverability through tortuous blood vessels, and improve patient comfort.
The Market For 3D Printed Bioresorbable CMF Plates And Other Complex Devices Is Being Redefined By New GMP-Grade Filament Material

The adoption of 3D printing technologies for implantable medical devices has been relatively slow and largely confined to metal-based implants traditionally used for hip, knee, and spine reconstruction applications. This has been due to challenges in sourcing the right biocompatible materials, validating processes, and adhering to quality and regulatory requirements.
Bioresorbable Copolymer Advances In Wound Healing, Pediatric Devices

Strong, fast-degrading bioresorbable polymers for use with wound healing and pediatric device applications has been a major area of unmet market need. Review an innovative new copolymer solution that leverages the properties of polyethylene glycol (PEG).
How To Optimize And Accelerate The 3D Printing And Testing Of Bioresorbable Device Parts

The convergence of modern 3D printing technologies such as selective laser sintering (SLS), fused filament fabrication (FFF), and bioplotters with a new generation of custom bioresorbable polymers in powder, filament, and granule is revolutionizing what’s possible in the development of bioresorbable medical device parts.
Prevention Of Thrombus Accumulation On Vascular Access Products Can Have Positive Impact

Thrombus accumulation on blood-contacting devices such as catheters, vascular stents, or hemodialyzers can lead to device failure or serious complications and has a significant impact on patient care, quality of life, and overall healthcare costs.
A GMP Implantable Grade Bioresorbable Polymer Powder Breakthrough For The 3D Printing Of Medical Devices Using SLS Technology

Selective Laser Sintering (SLS) systems use a high-powered laser to selectively melt and fuse powder particles of a bioresorbable polymer in a layer-by-layer 3D printing process to manufacture a final implantable medical device part. Depending on the part geometry, these systems can typically print geometries as small as 0.4 mm with a tolerance of +/- 0.25 mm.
How To Utilize Extrusion To Optimize Processing And Supply Of High-Quality Tubes For Use With Stents, Scaffolds, And Other Medical Devices

This interview with Dr. Thiago Borges covers how to utilize extrusion to optimize the processing and supply of high-quality tubes for use in stents, scaffolds, and other medical devices.
Reducing Bacterial Adhesion And Biofouling On Medical Device Surfaces: An Interview With Jeannette Ho

This interview with Jeannette Ho, the head of surface modification at Evonik, discusses opportunities for medical device companies to leverage a passive, stable, and durable technology platform to reduce bacterial adhesion and biofouling.
Recombinant Collagen Made Via Fermentation Addresses Unmet Market Needs

The production of recombinant collagen made via fermentation-based processes addresses market needs for collagen that is safe, sustainable, reproducible, and acceptable to consumers.
What 3D Printing Technology And Material Is Right For Your Medical Device Application?

In this interview with Balaji Prabhu, from Evonik’s Medical Device Competence Center in the U.S., we review how medical device companies can best evaluate current biomaterial options for the four leading 3D printing technologies.
A New Recombinant Collagen Platform Is Poised To Enhance The Safety, Performance And Acceptability Of Medical Devices

Collagen is one of the industry’s most important biomaterials. To address market needs for solubility, biocompatibility, processability, sustainability, and scalability, Evonik has developed a new recombinant collagen technology platform. Prospective medical device customers seeking product samples for feasibility studies or development programs can contact Evonik for further information.